warning 2 countries ICD-10 A980

Crimean-Congo haemorrhagic fever

Crimean-Congo haemorrhagic fever clinical and global spread profile: 2 countries, 2 WHO outbreak events since 1996.

Crimean-Congo haemorrhagic fever · ICD-10 A980 · ICD-11 1D49 · 2 WHO events across 2 countries (1996–2022).

Top affected countries

Country Region Events % of global
Iraq EMR 1 50%
South Africa AFR 1 50%

Decade summary

Decade Events
1990s 1
2020s 1

WHO case definition

A disease caused by an infection with Crimean-Congo haemorrhagic fever virus. The incubation period ranges from 2 to 9 days. Symptoms/signs typically include high fever, headache, malaise, arthralgia, myalgia, nausea, abdominal pain, and rarely diarrhoea. Early signs typically include fever, hypotension, conjunctivitis, and cutaneous flushing or a skin rash. Later, patients may develop signs of progressive haemorrhagic diathesis, such as petechiae, mucous membrane and conjunctival haemorrhage, haematuria, hematemesis, and melena. Lethality may reach 30%. Transmission occurs via bites of infected ticks, by direct contact with infected animal blood, or iatrogenic transmission. Laboratory diagnosis of the infection during the acute phase of illness consists of detection of viral nucleic acid or by isolation of the virus or by demonstration of viral antigen by enzyme-linked immunoassay from serum or plasma samples. In samples collected later during the illness, diagnosis is confirmed by demonstration of specific IgG and IgM antibodies.

Countries Affected

2

Outbreak Events

2

Year Range

1996–2022

coronavirus

ICD-10 A980

Crimean-Congo haemorrhagic fever

Visualization

Global Prevalence Snapshot

Based on WHO Disease Outbreak News events (1996–2022).

2 Outbreak events · Sporadic / Low

Risk Level

Endemic / High Risk
Emerging / Moderate
Sporadic / Low Risk

Continue exploring

Related Profiles